59 related articles for article (PubMed ID: 12451699)
1. [Role of brain prostaglandin biosynthesis in behavioral disorders induced by tetrahydrocannabinol in marihuana].
Yamaguchi T; Nobe S; Kubota T; Watanabe S; Yamamoto T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct; 22(5):209-10. PubMed ID: 12451699
[No Abstract] [Full Text] [Related]
2. [Cannabis--a drug with dangerous implications for mental health].
Shufman E; Witztum E
Harefuah; 2000 Mar; 138(5):410-3, 423. PubMed ID: 10883147
[TBL] [Abstract][Full Text] [Related]
3. Cannabis-induced hypothermia: a dose-effect comparison of crude marihuana extract and synthetic 9 -tetrahydrocannabinol in male and female rats.
Borgen LA; Lott GC; Davis WM
Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):621-6. PubMed ID: 4701259
[No Abstract] [Full Text] [Related]
4. Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion.
Gorriti MA; Ferrer B; del Arco I; Bermúdez-Silva FJ; de Diego Y; Fernandez-Espejo E; Navarro M; Rodríguez de Fonseca F
Pharmacol Biochem Behav; 2005 May; 81(1):71-7. PubMed ID: 15894066
[TBL] [Abstract][Full Text] [Related]
5. [Brain damage and marihuana].
Carranza-Acevedo J
Arch Invest Med (Mex); 1974; 5 SUPPL 1():187-94. PubMed ID: 4548640
[No Abstract] [Full Text] [Related]
6. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
Wallace M; Schulteis G; Atkinson JH; Wolfson T; Lazzaretto D; Bentley H; Gouaux B; Abramson I
Anesthesiology; 2007 Nov; 107(5):785-96. PubMed ID: 18073554
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids attenuate norepinephrine-induced melatonin biosynthesis in the rat pineal gland by reducing arylalkylamine N-acetyltransferase activity without involvement of cannabinoid receptors.
Koch M; Dehghani F; Habazettl I; Schomerus C; Korf HW
J Neurochem; 2006 Jul; 98(1):267-78. PubMed ID: 16805813
[TBL] [Abstract][Full Text] [Related]
8. Metabolic products of arachidonic acid in the central nervous system: possible role in mental disorders.
Mathé AA; Apéria B; Bergman P; Eberhard G; Jerling M; Lindström L; Sääf J; Undén F; Wetterberg L
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():958-62. PubMed ID: 2960211
[No Abstract] [Full Text] [Related]
9. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol.
Verty AN; McGregor IS; Mallet PE
Brain Res; 2004 Sep; 1020(1-2):188-95. PubMed ID: 15312802
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the apoptotic effect of Delta(9)-tetrahydrocannabinol in the neonatal and adult rat cerebral cortex.
Downer EJ; Gowran A; Campbell VA
Brain Res; 2007 Oct; 1175():39-47. PubMed ID: 17884022
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
Fox SH; Henry B; Hill M; Crossman A; Brotchie J
Mov Disord; 2002 Nov; 17(6):1180-7. PubMed ID: 12465055
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effect of germanium-concentrated yeast against paw oedema is related to the inhibition of arachidonic acid release and prostaglandin E production in RBL 2H3 cells.
Lee JH; Kim KW; Yoon MY; Lee JY; Kim CJ; Sim SS
Auton Autacoid Pharmacol; 2005 Oct; 25(4):129-34. PubMed ID: 16176443
[TBL] [Abstract][Full Text] [Related]
13. Kinins and neuroinflammation: dual effect on prostaglandin synthesis.
Levant A; Levy E; Argaman M; Fleisher-Berkovich S
Eur J Pharmacol; 2006 Sep; 546(1-3):197-200. PubMed ID: 16889769
[TBL] [Abstract][Full Text] [Related]
14. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity.
Singh ME; McGregor IS; Mallet PE
Neuropharmacology; 2005 Dec; 49(8):1189-200. PubMed ID: 16137723
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
16. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.
D'Souza DC; Abi-Saab WM; Madonick S; Forselius-Bielen K; Doersch A; Braley G; Gueorguieva R; Cooper TB; Krystal JH
Biol Psychiatry; 2005 Mar; 57(6):594-608. PubMed ID: 15780846
[TBL] [Abstract][Full Text] [Related]
17. On the pharmacological properties of Delta9-tetrahydrocannabinol (THC).
Costa B
Chem Biodivers; 2007 Aug; 4(8):1664-77. PubMed ID: 17712813
[TBL] [Abstract][Full Text] [Related]
18. Role of insulin on PGE2 generation during LPS-induced lung inflammation in rats.
Alba-Loureiro TC; Martins EF; Landgraf RG; Jancar S; Curi R; Sannomiya P
Life Sci; 2006 Jan; 78(6):578-85. PubMed ID: 16143347
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.
Patel S; Hillard CJ
J Pharmacol Exp Ther; 2006 Jul; 318(1):304-11. PubMed ID: 16569753
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia.
Ryan D; Drysdale AJ; Pertwee RG; Platt B
Neurosci Lett; 2006 Nov; 408(3):236-41. PubMed ID: 16997463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
